tiprankstipranks
COSMO Pharmaceuticals N.V. (GB:0RGI)
LSE:0RGI

COSMO Pharmaceuticals N.V. (0RGI) Financial Statements

0 Followers

COSMO Pharmaceuticals N.V. Financial Overview

COSMO Pharmaceuticals N.V.'s market cap is currently ―. The company's EPS TTM is CHF-0.292; its P/E ratio is -247.43; and it has a dividend yield of 1.42%. COSMO Pharmaceuticals N.V. is scheduled to report earnings on July 24, 2024, and the estimated EPS forecast is CHF0.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 240.95M€ 218.97M€ 222.21M€ 203.13M€ 212.85M
Total Assets€ 759.59M€ 765.25M€ 805.56M€ 562.76M€ 596.16M
Total Debt€ 173.60M€ 171.83M€ 169.92M€ 168.12M€ 168.14M
Net Debt€ -67.36M€ -47.14M€ -52.29M€ -35.02M€ -44.71M
Total Liabilities€ 295.80M€ 296.03M€ 292.88M€ 191.76M€ 196.04M
Stockholders Equity€ 456.93M€ 462.54M€ 505.28M€ 371.00M€ 400.13M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

COSMO Pharmaceuticals N.V. Earnings and Revenue History

COSMO Pharmaceuticals N.V. Debt to Assets

COSMO Pharmaceuticals N.V. Cash Flow

COSMO Pharmaceuticals N.V. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis